Karolinska Institutet | Interview with Michel Sadelain @karolinskainstitutet | Uploaded 5 years ago | Updated 14 hours ago
Michel A. Sadelain, MD, PhD, Director of the Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York City.

In November 2018, Karolinska Institutet was visited by Michel Sadelain, a pioneer in the field of cancer immunotherapy called "CAR T-cell therapy". He visited KI for a symposium celebrating the ten year anniversary of Dr Åke Olsson's foundation for haematology research.
Michel Sadelain is also director of the Center for Cell Engineering at the Memorial Sloan Kettering Cancer Center in New York. Here he tells us about his field of research.